Publications:34
Shyamala Navada, MD, MSCR
About Me
Dr. Navada is an Adjunct Associate Professor in the Department of Medicine
Language
English
Position
ADJUNCT ASSOCIATE PROFESSOR | Medicine, Hematology and Medical Oncology
Research Topics
Cancer, Leukemia
Clinical Focus
- Anemia
- Aplastic Anemia
- Blood Transfusion
- Bone Marrow Biopsy
- Leukemia
- Myelodysplastic Syndromes
- Primary Polycythemia
Publications
Selected Publications
- Association between treatment-emergent cytopenias and clinical responses to imetelstat in lower-risk myelodysplastic syndromes. Amer M. Zeidan, Valeria Santini, María Díez-Campelo, Michael R. Savona, Mikkael A. Sekeres, Yazan F. Madanat, Pierre Fenaux, Azra Raza, Moshe Mittelman, Sylvain Thépot, Rena Buckstein, Ulrich Germing, David Valcárcel, Anna Jonášová, Sheetal Shah, Qi Xia, Libo Sun, Shyamala Navada, Tymara Berry, Uwe Platzbecker, Rami S. Komrokji. Blood Cancer Journal
- Increased duration of time without transfusion reliance with imetelstat vs placebo in the phase 3 IMerge trial. Mikkael A. Sekeres, Valeria Santini, Amer M. Zeidan, Uwe Platzbecker, Rami S. Komrokji, María Díez-Campelo, Pierre Fenaux, Michael R. Savona, Yazan F. Madanat, David Valcárcel, Antoine Regnault, Flora Mazerolle, Libo Sun, Ying Wan, Tymara Berry, Faye Feller, Shyamala Navada, Esther Natalie Oliva. Blood Neoplasia
- Modulation of the clonal burden in patients with lower-risk myelodysplastic neoplasms treated with imetelstat. Valeria Santini, Amer M. Zeidan, Koen Van Eygen, Pierre Fenaux, Ulrich Germing, Yazan F. Madanat, Azra Raza, Michael R. Savona, Mikkael A. Sekeres, Sylvain Thépot, Marco G. Raddi, Thomas Boyer, Libo Sun, Ying Wan, Tymara Berry, Qi Xia, Fei Huang, Souria Dougherty, Shyamala Navada, Faye Feller, Rami S. Komrokji, Uwe Platzbecker. Leukemia
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Navada during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Outside Employment
- Geron Corporation
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.